PHIO PHARMACEUTICALS CORP

Phio insider buying signals confidence amid biotech rally. Learn why executives’ purchases may boost value and what to watch for in its cancer immunotherapy pipeline.

PHIO PHARMACEUTICALS insider buying spikes investor confidence as CEO buys 10,000 shares, hinting at a potential biotech turnaround.

Phio Pharmaceuticals’ insider buying spurs confidence in its oncology pipeline, yet investors must watch clinical milestones and funding moves for real value.